United States Antimony Corp (AMEX:UAMY) does about 2.53M shares in volume on a normal day but saw 7228655 shares change hands in the recent trading day. The company now has a market cap of 359.94M USD. Its current market price is $3.14, marking an increase of 12.54% compared to the previous close of $2.79. The 52 week high reached by this stock is $2.87 whilst the lowest price level in 52 weeks is $0.21.
United States Antimony Corp (UAMY) has a 20-day trading average at $2.22 and the current price is 9.41% off the 52-week high compared with 1395.24% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.87 and its 200-day simple moving average is $1.12. If we look at the stock’s price movements over the week, volatility stands at 13.99%, which decreases to 12.38% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 76.69 to suggest the stock is overbought.
The consensus objective for the share price is $2.78, suggesting that the stock has a potential downside of -12.95% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on March 21, 2025 when B. Riley Securities initiated the stock to “Buy” and issued a price target of $3.
The current price level is 41.12%, 67.88%, and 179.69% away from its SMA20, SMA50, and SMA200 respectively, with the UAMY price moving below the 50-day SMA on current market day. United States Antimony Corp (UAMY) stock is up 56.22% over the week and 85.80% over the past month. Its price is 77.40% year-to-date and 1164.09% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0.06 for whole year. Expected sales for next quarter are $8.84M, which analysts say will come at $42.52M for the current fiscal year and next year at $99.24M. In addition, estimates put the company’s current quarterly revenue at an average of $7.02M.
To reach the target analysts have set, the stock logically needs to shrink -12.95 percent from here.
The company has a return on investment of -6.01% and return on equity of -6.39%. The forward price to earnings ratio is 10.64. The beta has a value of 0.12. Price to book ratio is 12.40 and price to sales ratio is 24.09.
